NIAID | Technology Transfer

Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Read more about Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

European Patent
20153909.5
Filed on 2020-01-27

Neutralizing Antibodies to GP120 and Their Use

Read more about Neutralizing Antibodies to GP120 and Their Use

European Patent
20156388.9
Filed on 2016-03-18

HUMAN IMMUNODEFICIENCY VIRUS-SPECIFIC T CELL RECEPTORS

Read more about HUMAN IMMUNODEFICIENCY VIRUS-SPECIFIC T CELL RECEPTORS

Patent Cooperation Treaty
PCT/US2020/013698
Filed on 2020-01-15

lNEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE

Read more about lNEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE

US Application 16/786,267
Filed on 2020-02-10

LIVE ATTENUATED VIRUS VACCINES FOR LA CROSSE VIRUS AND OTHER BUNYAVIRIDAE

Read more about LIVE ATTENUATED VIRUS VACCINES FOR LA CROSSE VIRUS AND OTHER BUNYAVIRIDAE

US Application 16/750,437
Filed on 2020-01-23

Novel Multivalent Nanoparticle-Based Vaccines

Read more about Novel Multivalent Nanoparticle-Based Vaccines

Australia
2020200303
Filed on 2020-01-15

Antibody Evolution Immunogens

Read more about Antibody Evolution Immunogens

United Kingdom
13837551.4
Filed on 2013-09-12

Antibody Evolution Immunogens

Read more about Antibody Evolution Immunogens

France
13837551.4
Filed on 2013-09-12

Antibody Evolution Immunogens

Read more about Antibody Evolution Immunogens

Germany
13837551.4
Filed on 2013-09-12

HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS

Read more about HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS

US Patent 11,535,651
Filed on 2020-01-30

Subscribe to NIAID